Tuesday, June 04, 2019 6:25:48 PM
So is that why scam company ISCO has been avoiding clinical trials in the U.S. and now conducting them in other countries like Australia?
https://www.otcmarkets.com/stock/ISCO/news/International-Stem-Cell-Corporation-Completes-Enrollment-and-Dosing-in-its-Parkinsons-Disease-Clinical-Trial?id=226152
https://www.otcmarkets.com/stock/ISCO/news/International-Stem-Cell-Corporation-Completes-Enrollment-and-Dosing-in-its-Parkinsons-Disease-Clinical-Trial?id=226152
Correct... It's an article, not a press release. I first saw this on the FDA site. But, it's still unrelated to ISCO since different types of stem cells are used along with different methods.
Just like not all tech is the same. Not all stem cells are the same.
ISCO has a type of stem cell technology that should eliminate most issues facing stem cell companies. It's a tough nut to crack since most stem cell therapies cause enough harm that they are too risky.... that's why so many are out of business. Go to ISCO site and read about how they derive their stem cells.
It will be interesting to see final results of the Parkinson trial.
Dilution has been the main problem here.
Recent ISCO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:00:37 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2026 08:35:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:29:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2025 10:18:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:00:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2025 01:57:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2025 12:21:17 PM
